← Leaderboards
Carole A Oskeritzian
Virginia Commonwealth University
$3,176,471
Attributed
$3,377,530
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $354.5K · FY2006–25$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,377,530 · 8
By mechanism
R01$1,369,543 · 1
R21$1,301,981 · 4
K01$522,387 · 1
P20$178,619 · 1
R13$5,000 · 1
Top collaborators
- Lydia Eleanor Matesic1 shared
- Mitzi Nagarkatti1 shared
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Sarah Spiegel$20,919,449
- Ningjun Li$8,697,975
- Daniel H Conrad$9,937,904
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMast CellSphingolipidsSphingosine 1-PhosphateInflammationPreventPathway InteractionsMediatingInnovationInflammatoryRegulationAllergicChemokineCell PhysiologyMediator Of Activation ProteinPlayCytokineAffinityEventTissuesMouse ModelBaseSignal TransductionCrosslink
Grant awards (19)
Unraveling FcepsilonRI-independent regulation of mast cell functions by the ITCH ubiquitin ligase$223,500
R21 · FY2025 · AI · contact PI
Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity$165,436
R21 · FY2024 · CA · contact PI
Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity$208,973
R21 · FY2023 · CA · contact PI
Targeting early ceramide elevation in pre-symptomatic eczema$178,619
P20 · FY2022 · GM · contact PI
Development of a noninvasive, rapid and affordable method for early detection of colorectal cancer$103,582
R21 · FY2022 · CA · contact PI
Development of a noninvasive, rapid and affordable method for early detection of colorectal cancer$68,447
R21 · FY2021 · CA · contact PI
Development of a noninvasive, rapid and affordable method for early detection of colorectal cancer$208,973
R21 · FY2020 · CA · contact PI
MicroRNAs in atopic dermatitis pathogenesis: a role for mast cell and sphingosine-1-phosphate?$146,850
R21 · FY2017 · AR · contact PI
MicroRNAs in atopic dermatitis pathogenesis: a role for mast cell and sphingosine-1-phosphate?$176,220
R21 · FY2016 · AR · contact PI
Mast Cell S1P Receptor2 in the initiation and progression of chronic inflammation$345,252
R01 · FY2015 · AI · contact PI
Mast Cell S1P Receptor2 in the initiation and progression of chronic inflammation$345,252
R01 · FY2014 · AI · contact PI
Mast Cell S1P Receptor2 in the initiation and progression of chronic inflammation$324,537
R01 · FY2013 · AI · contact PI
48th Annual South Eastern Regional Lipid Conference (SERLC) Funding Support$5,000
R13 · FY2013 · GM · contact PI
Mast Cell S1P Receptor2 in the initiation and progression of chronic inflammation$354,502
R01 · FY2012 · AI · contact PI
Sphingosine-1-Phosphate, A Novel Mediator of Human Skin Mass Cell Functions$109,448
K01 · FY2010 · AR · contact PI
Sphingosine-1-Phosphate, A Novel Mediator of Human Skin Mass Cell Functions$106,889
K01 · FY2009 · AR · contact PI
Sphingosine-1-Phosphate, A Novel Mediator of Human Skin Mass Cell Functions$104,405
K01 · FY2008 · AR · contact PI
Sphingosine-1-Phosphate, A Novel Mediator of Human Skin Mass Cell Functions$101,993
K01 · FY2007 · AR · contact PI
Sphingosine-1-Phosphate, A Novel Mediator of Human Skin Mass Cell Functions$99,652
K01 · FY2006 · AR · contact PI